NDC 70518-4128-01 - Glipizide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4128
- Requested NDC
- 70518-4128-01
- Package NDCs from labels
- 70518-4128-0, 70518-4128-1, 70518-4128-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glipizide - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4128-0 | Glipizide | 30 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 30 | 4 | |
| 70518-4128-1 | Glipizide | 90 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-4128 | GLIPIZIDE (GLIPIZIDE) TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] | 1 | Current NDC, 2 package rows | 20240703_667dd68a-d3e7-4b50-bd0a-d17783a090d5.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Artificial Tears Lubricant Eye Drops | GLYCERIN, PROPYLENE GLYCOL | CVS Pharmacy | 28297fee-8185-4869-8f39-5bfbf8bf8bfd | 2026-04-13 | Warnings | 6DC9Q167V3 |
| Retaine Ultra PF | POLYETHYLENE GLYCOL | OCuSOFT LLC | a5aaaf06-772d-44d3-8601-f978ddc48ad7 | 2026-04-13 | Warnings | 6DC9Q167V3 B697894SGQ |
| Glipizide | GLIPIZIDE | Bryant Ranch Prepack | 4afa67b2-7f86-4189-93a5-6a605f74540d | 2026-04-09 | Warnings, Adverse reactions | ANDA206928 314006 X7WDT95N5C |
| Crocodile Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Crocodile Tears LLC | 4df29336-ea0c-0484-e063-6294a90a685a | 2026-03-26 | Warnings | B697894SGQ |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | a34b58ac-42b2-4a19-a28b-cb3144ea55cd | 2026-03-26 | Warnings, Adverse reactions | 314006 X7WDT95N5C |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | KC Pharmaceuticals, Inc | 4de5c844-85ca-ff9f-e063-6394a90ac12c | 2026-03-25 | Warnings | B697894SGQ |
| BLINK TRIPLE CARE | POLYETHYLENE GLYCOL 400 | Bausch & Lomb Incorporated | a2b34eb0-001b-4f42-a8cc-c2a0150fafcc | 2026-03-20 | Warnings | B697894SGQ |
| Glipizide | GLIPIZIDE | Major Pharmaceuticals | d3b5677c-2265-47c8-beeb-bf12106056ba | 2026-03-13 | Warnings, Adverse reactions | X7WDT95N5C |
| Leader Ultra Lubricating Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Cardinal Health | d7f011a2-05ba-47c3-9519-d31602e105c7 | 2026-03-12 | Warnings | 6DC9Q167V3 B697894SGQ |
| Leader Restorative Formula Lubricant Eye Drops | PROPYLENE GLYCOL | Cardinal Health | 87fef7e4-e5a8-4aad-94d2-f80f34826d97 | 2026-03-12 | Warnings | 6DC9Q167V3 |
| Leader Advanced Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Cardinal Health | 5c5d6c13-9b51-48f0-8627-b60b0f707fd3 | 2026-03-12 | Warnings | B697894SGQ |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 4a2d814b-93a1-4487-b789-dbafe9f0ffd3 | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | Advagen Pharma Limited | e954afb8-52eb-416a-8f1b-14b0fcb3bac2 | 2026-03-06 | Warnings, Adverse reactions | X7WDT95N5C |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | B697894SGQ |
| Glipizide | GLIPIZIDE | Legacy Pharmaceutical Packaging, LLC | 116ffc6a-735c-49e0-a9d5-69b6bc3e3706 | 2026-03-03 | Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | REMEDYREPACK INC. | e593552f-9817-4cb5-b491-31ea57dea4b8 | 2026-02-24 | Warnings, Adverse reactions | 315107 X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 9c9a3688-6de9-41db-af82-c4aa9b5b3f92 | 2026-02-20 | Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | PD-Rx Pharmaceuticals, Inc. | f60b0690-aca9-40ec-956e-bd2ecc35ec54 | 2026-02-16 | Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 383540fd-2931-49bf-8009-25e8f7fc9bda | 2026-02-10 | Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | a38cfe61-4aa5-498c-bca5-03a8213303bb | 2026-02-10 | Warnings, Adverse reactions | X7WDT95N5C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.